相关实验视频
Updated: Jan 12, 2026

Facile Preparation and Photoactivation of Prodrug-Dye Nanoassemblies
Published on: February 17, 2023
基于原药的药物输送系统:针对性治疗的战略方法和新出现的挑战
Priyanka Chaturvedi1, Reena Sharma2, Smita Khare3
1Department of Pharmaceutics, Jai Narain College of Pharmacy, JNCT Professional University, Lambakheda, Barasia road, Bhopal, Madhya Pradesh, 462038, India.
前药物输送系统通过暂时修改活性药物成分 (API) 来提高药物的有效性和安全性. 化学修饰和纳米载体系统的创新解决了诸如不稳定性和非目标效应等挑战,以改善治疗方法.
科学领域:
- 制药科学 制药科学
- 药物运输 药物运输 药物运输
- 纳米技术 纳米技术
背景情况:
- 传统药物配方面临的局限性包括溶解性差,生物可用性低和全身毒性.
- 前药物策略暂时修改活性药物成分 (API),以提高治疗疗效和安全性.
- 最近的进展集中在前药物设计和输送系统上,特别是在过去十年.
研究的目的:
- 批判性地评估目前的进展,挑战和前药物设计和交付的未来方向.
- 专注于增强药理动力学,目标特异性和受控释放的策略.
- 审查创新的前药物方法,输送系统和纳米技术应用.
主要方法:
- 预先药物策略的分类为化学修饰和载体介导输送.
- 对研究的审查,重点关注可溶性和稳定性的共价链接,以及针对性传递的纳米载体.
- 重点是最近的创新,如刺激响应系统和表面功能化载体.
主要成果:
- 产药系统显著提升了药物输送,使得有针对性和可控的治疗干预成为可能.
- 化学修饰改变了API的特性 (溶解性,脂性,稳定性).
- 载体介导的传递利用纳米载体 (脂质体,纳米颗粒,树脂体,体) 改善向和减少系统性暴露.
结论:
- 尽管取得了进展,但诸如前期药物不稳定性,过早释放和潜在毒性等挑战仍然存在.
- 诸如理性链接器设计和刺激响应系统等创新,在克服局限性方面显示出有前途.
- 未来的研究应该优先考虑临床适用性的翻译方法,以计算工具和先进的生物材料为支持.
更多相关视频
10:16Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier
Published on: February 8, 2017
14:20Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
相关概念视频
Prodrugs
Prodrugs help overcome...
Drug Delivery: Overview
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Drug Discovery: Overview
Biopharmaceutical Factors Influencing Drug Product Design: Overview
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...